
A one-year exercise intervention trial involving 295 patients showed a 45% relative reduction in atrial fibrillation burden compared to usual care, according to results presented at ESC Congress 2026.
Participants in the study, who had a mean age of 64, experienced a 37% reduction in total hospitalizations and a 46% decrease in AF-related hospital admissions over the follow-up period.
The hybrid program combined eight weeks of supervised high-intensity sessions with long-term remote monitoring via smartwatches and apps, proving to be a clinically feasible management strategy.